Covid-19 vaccine effectiveness studies in Nigeria: Quo vadis?
Loading...
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
International Society of Global Health
Abstract
The “lickety-split” development of COVID-19 vaccines 326 days from when the SARS-COV-2 virus was
first sequenced is indeed one of the public health successes of the 21st century. Particularly because an
18-month target was initially considered reasonable, and having achieved this success, a “moonshot”
goal to ensure that a vaccine is available within 100 days after the next pandemic pathogen is recognized has
been set [1].
Description
Keywords
Covid-19, Public health, Vaccine, Nigeria, World Health Organisation (WHO)
Citation
Akande, O. W. et al. (2022). Covid-19 vaccine effectiveness studies in Nigeria: Quo vadis?. Journal of global health, 12, 03055. 10.7189/jogh.12.03055